We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Pharmacogenomics: Relevance and opportunities for clinical pharmacology.
- Authors
Turner, Richard M.; Magavern, Emma F.; Pirmohamed, Munir
- Abstract
Pharmacogenonomics (PGx) is the intersection of genomic medicine and pharmacology whereby knowledge of variation in an individual's genome is utilized to inform prescribing practice. In conclusion, PGx represents a novel piece in the jigsaw of factors that should be collectively considered when developing novel drugs and prescribing current drugs to improve the safety and efficacy of pharmacotherapy. For instance, it is possible that some clinical pharmacologists with a particular interest in PGx may become PGx specialists, similar to how some clinical pharmacologists have specialized in hypertension or clinical toxicology.
- Subjects
PHARMACOGENOMICS; CLINICAL pharmacology; CHLORIDE channels; MEDICAL personnel; DRUG side effects; CYSTIC fibrosis transmembrane conductance regulator; CLINICAL decision support systems
- Publication
British Journal of Clinical Pharmacology, 2022, Vol 88, Issue 9, p3943
- ISSN
0306-5251
- Publication type
Article
- DOI
10.1111/bcp.15329